143 related articles for article (PubMed ID: 12653600)
1. Diffuse neuroendocrine differentiation in a morphologically composite mammary infiltrating ductal carcinoma: a case report and review of the literature.
David O; Bhattacharjee M
Arch Pathol Lab Med; 2003 Mar; 127(3):e131-4. PubMed ID: 12653600
[TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine carcinomas of the breast.
Rovera F; Masciocchi P; Coglitore A; La Rosa S; Dionigi G; Marelli M; Boni L; Dionigi R
Int J Surg; 2008; 6 Suppl 1():S113-5. PubMed ID: 19167937
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer with neuroendocrine differentiation detected by unique staining pattern of neoplastic cells in hercep test.
Mieda J; Ohaki Y; Oguro T; Shimizu H; Akasaka K; Kyomoto A; Kurokawa M; Arai S; Mori O; Okada S; Kyono S; Tanaka N
J Nippon Med Sch; 2004 Jun; 71(3):203-8. PubMed ID: 15226612
[TBL] [Abstract][Full Text] [Related]
4. Primary neuroendocrine tumor of the breast: imaging features.
Chang ED; Kim MK; Kim JS; Whang IY
Korean J Radiol; 2013; 14(3):395-9. PubMed ID: 23690703
[TBL] [Abstract][Full Text] [Related]
5. Primary neuroendocrine carcinoma of the breast.
Akhtar K; Zaheer S; Ahmad SS; Hassan MJ
Indian J Pathol Microbiol; 2009; 52(1):71-3. PubMed ID: 19136787
[TBL] [Abstract][Full Text] [Related]
6. Is CD56 a specific and reliable neuroendocrine marker for discriminating between endocrine/neuroendocrine ductal carcinoma in situ and intraductal papilloma of the breast?
Kawasaki T; Kondo T; Nakazawa T; Mochizuki K; Yamane T; Murata S; Inoue S; Tsunoda H; Katoh R
Pathol Int; 2011 Jan; 61(1):49-51. PubMed ID: 21166944
[No Abstract] [Full Text] [Related]
7. Synchronous bilateral neuroendocrine ductal carcinoma in situ.
Honami H; Sotome K; Sakamoto G; Iri H; Tanaka Y; Fukamachi S; Morozumi K
Breast Cancer; 2014 Jul; 21(4):508-13. PubMed ID: 21735237
[TBL] [Abstract][Full Text] [Related]
8. [Breast carcinoma with predominant neuroendocrine differentiation].
Frachon S; Pasquier D; Treilleux I; Seigneurin D; Ringeisen F; Rosier P; Bolla M; Boutonnat J
Ann Pathol; 2004 Jun; 24(3):278-83. PubMed ID: 15480266
[TBL] [Abstract][Full Text] [Related]
9. Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature.
Angarita FA; RodrÃguez JL; Meek E; Sánchez JO; Tawil M; Torregrosa L
World J Surg Oncol; 2013 Jun; 11():128. PubMed ID: 23734899
[TBL] [Abstract][Full Text] [Related]
10. Invasive mammary carcinoma with neuroendocrine differentiation: histological features and diagnostic challenges.
Tang F; Wei B; Tian Z; Gilcrease MZ; Huo L; Albarracin CT; Resetkova E; Zhang H; Sahin A; Chen J; Bu H; Abraham S; Wu Y
Histopathology; 2011 Jul; 59(1):106-15. PubMed ID: 21668471
[TBL] [Abstract][Full Text] [Related]
11. Loss of cell cohesion in breast cytology as a characteristic of neuroendocrine carcinoma.
Tang W; Taniguchi E; Wang X; Mori I; Kagiya T; Yang Q; Nakamura Y; Nakamura M; Yoshimura G; Sakurai T; Kakudo K
Acta Cytol; 2002; 46(5):835-40. PubMed ID: 12365216
[TBL] [Abstract][Full Text] [Related]
12. Collision tumour of the breast composed of Merkel cell carcinoma and invasive ductal carcinoma: a case report.
Nedved D; Connor C; Sharma P; O'Neil M
Pathologica; 2014 Mar; 106(1):16-21. PubMed ID: 24897776
[TBL] [Abstract][Full Text] [Related]
13. Neuroendocrine differentiation in breast carcinoma with osteoclast-like giant cells. Report of a case and review of the literature.
Cozzolino I; Ciancia G; Limite G; Di Micco R; Varone V; Cortese A; Vatrella A; Di Crescenzo V; Zeppa P
Int J Surg; 2014; 12 Suppl 2():S8-S11. PubMed ID: 25204617
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of primary mammary small cell carcinoma, carcinoma with endocrine features and invasive ductal carcinoma.
Yamamoto J; Ohshima K; Nabeshima K; Ikeda S; Iwasaki H; Kikuchi M
Oncol Rep; 2004 Apr; 11(4):825-31. PubMed ID: 15010880
[TBL] [Abstract][Full Text] [Related]
15. Solid neuroendocrine carcinoma of the breast.
Abbasi NZ; Zahur Z; Sheikh AS; Khan AA; Ali F; Memon KH; Moizuddin SS; Loya A; Barkat N
J Coll Physicians Surg Pak; 2013 Nov; 23(10):820-2. PubMed ID: 24169396
[TBL] [Abstract][Full Text] [Related]
16. Histopathological and Clinical Differences Between Primary Breast Carcinomas With Neuroendocrine Features and Primary Breast Carcinomas Mimicking Neuroendocrine Features.
Kelten Talu C; Savli TC; Huq GE; Leblebici C
Int J Surg Pathol; 2019 Oct; 27(7):744-752. PubMed ID: 31195855
[TBL] [Abstract][Full Text] [Related]
17. Is there a role for hormonal therapy in neuroendocrine carcinoma of the breast? A Paradigmatic case report.
Pagano M; Asensio SN; Zanelli F; Lococo F; Cavazza A; Damiani S; Rapicetta C; Gnoni R; Boni C
Clin Breast Cancer; 2014 Oct; 14(5):e99-e101. PubMed ID: 24958323
[No Abstract] [Full Text] [Related]
18. Double neuroendocrine ductal carcinomas in situ coexisting with a background of diffuse idiopathic neuroendocrine cell hyperplasia of breast: a case report and hypothesis of neuroendocrine tumor development.
Miura K; Nasu H; Ogura H
Pathol Int; 2012 May; 62(5):331-4. PubMed ID: 22524661
[TBL] [Abstract][Full Text] [Related]
19. In situ and infiltrating ductal carcinoma arising in a breast hamartoma.
Mester J; Simmons RM; Vazquez MF; Rosenblatt R
AJR Am J Roentgenol; 2000 Jul; 175(1):64-6. PubMed ID: 10882247
[No Abstract] [Full Text] [Related]
20. Mucinous carcinoma of the breast: a comparative study on cytohistological findings associated with neuroendocrine differentiation.
Ohashi R; Sakatani T; Matsubara M; Watarai Y; Yanagihara K; Yamashita K; Tsuchiya S; Takei H; Naito Z
Cytopathology; 2016 Jun; 27(3):193-200. PubMed ID: 26804749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
